Abstract:Abstract Colorectal cancer harbors heterogeneous cell populations that contribute to tumor progression. Clones with long term tumor-initiating cell activity are thought to fuel colorectal cancer (CRC) metastasis formation and recent reports suggest that drug tolerant persister cells are endowed with the ability to replenish the tumor during relapse upon therapy. To decipher gene expression heterogeneity of sub-populations within individual clones, we link gene expression states to clonal dynamics in metastatic and therapy resistant sub-populations. We transduced CRC patient-derived organoids with CloneTracker XPTM library, which bears stable genetic barcodes expressed on the RNA level. 300,000 uniquely barcoded cells were either passaged with and without drugs treatment (5-fluorouracil, oxaliplatin and irinotecan) in vitro or serially transplanted orthotopically into immune deficient NSG mice. At determined endpoints, cells or xenograft tumors were harvested and analyzed for clonal dynamics and sub-clonal gene expression programs associated to tumor progression and therapy resistance, respectively using single cell RNA and barcode DNA sequencing.Integrated bioinfomatic analyses of scRNA data from more than 35,000 cells before, during and after recovery from in vitro drug treatment linked clonal barcodes to gene expression of individual cells. The clonal complexity score, i.e number of distinct clones/number of cells, remained stable before and after treatment, suggesting that the clonal composition of the cell population was marginally affected by chemotherapy. After recovery, single cell gene expression data reflected that individual clones contain cells in distinct transcriptional states, with an elevated proportion expressing the intestinal stem-like program. In addition, single cell and bulk barcode analysis of transplanted xenografts revealed that the bulk of tumor and metastasis in liver and lung is formed by a subfraction of 0.006% of all transplanted clones, indicating a strong clonal selection. In serial transplantations of metastasis, only 4 to 5 clones constituted more than 90% of cancer cell bulk. Regarding gene expression in tumor, individual cell subpopulations within the same clone were distributed within 12 different gene expression clusters, which were maintained in metastasis. Overall, our results indicate that multiple clones contribute to both metastasis and therapy resistance and suggest that intra-tumoral heterogeneity is driven by modulation of subclonal gene expression programs. Here, we provide insights into subclonal gene expression heterogeneity and identify transcriptional states which may be potentially relevant for tumor progression and therapy resistance. This may provide the basis for the future development and testing of innovative novel treatment strategies directed against these cellular states. Citation Format: M Haidar Kasem, Attila Jády, Jan-Philipp Mallm, Hanno Glimm, Sebastian M. Dieter, Friederike Herbst, Claudia R. Ball. Single cell lineage analysis reveals clonal evolution and dynamic intra-clonal gene expression states during colorectal cancer progression [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 136.

Pre-existing subclones determine radioresistance in rectal cancer organoids

Patient-Derived Organoids (Pdo) As The Potential Model To Predict Treatment Outcome Of Rectal Cancer Patients Underwent Neo-Adjuvant Chemoradiotherapy

Organoids Reveal That Inherent Radiosensitivity of Small and Large Intestinal Stem Cells Determines Organ Sensitivity.

Abstract A06: Exploring Mechanisms of Colorectal Tumor Radioresistance in Organoids

Abstract 6946: Unravelling intra-tumor phenotypic heterogeneity in colorectal cancer organoids

Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification

Abstract 136: Single cell lineage analysis reveals clonal evolution and dynamic intra-clonal gene expression states during colorectal cancer progression

Supplementary Data from Organoids Reveal That Inherent Radiosensitivity of Small and Large Intestinal Stem Cells Determines Organ Sensitivity

Novel Tumor Organoid-Based Mouse Model to Study Image Guided Radiation Therapy of Rectal Cancer After Noninvasive and Precise Endoscopic Implantation

Abstract B008: Modeling radiation sensitivity in patient-derived organoid models of endometrial cancer

Abstract 692: Patient-derived co-cultures of TRACERx lung cancer organoids and autologous T-cells reveal heterogeneity in immune evasion between cancer subclones

Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer

Transcriptomic analyses of the radiation response in head and neck squamous cell carcinoma subclones with different radiation sensitivity: time-course gene expression profiles and gene association networks

Colorectal Cancer Patient‐Derived 2D and 3D Models Efficiently Recapitulate Inter‐ and Intratumoral Heterogeneity

Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients

Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer

Abstract 6016: Patient-derived tumor organoid cultures identify a chemo-resistant sub-population in esophageal squamous cell carcinoma

Abstract 224: Combining functional precision medicine and radiotherapy with bio-printed organoids in head and neck squamous cell carcinoma

Early evolutionary branching across spatial domains predisposes to clonal replacement under chemotherapy in neuroblastoma

Integrated chromatin and transcriptomic profiling of patient-derived colon cancer organoids identifies personalized drug targets to overcome oxaliplatin resistance

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers